Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials

AB Kunnumakkara, M Hegde, D Parama… - ACS Pharmacology & …, 2023 - ACS Publications
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …

The polygenic architecture of schizophrenia—rethinking pathogenesis and nosology

OB Smeland, O Frei, AM Dale… - Nature Reviews …, 2020 - nature.com
Schizophrenia is a severe psychiatric disorder with considerable morbidity and mortality.
Although the past two decades have seen limited improvement in the treatment of …

Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia

SK Brannan, S Sawchak, AC Miller… - … England Journal of …, 2021 - Mass Medical Soc
Background The muscarinic receptor agonist xanomeline has antipsychotic properties and
is devoid of dopamine receptor–blocking activity but causes cholinergic adverse events …

[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia

American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

[HTML][HTML] The (poly) pharmacology of cannabidiol in neurological and neuropsychiatric disorders: molecular mechanisms and targets

RM Vitale, FA Iannotti, P Amodeo - International journal of molecular …, 2021 - mdpi.com
Cannabidiol (CBD), the major nonpsychoactive Cannabis constituent, has been proposed
for the treatment of a wide panel of neurological and neuropsychiatric disorders, including …

Development of a machine learning based algorithm to accurately detect schizophrenia based on one-minute EEG recordings

R Buettner, D Beil, S Scholtz, A Djemai - 2020 - scholarspace.manoa.hawaii.edu
While diagnosing schizophrenia by physicians based on patients' history and their overall
mental health is inaccurate, we report on promising results using a novel, fast and reliable …

Neuroimaging in schizophrenia

MS Keshavan, G Collin, S Guimond… - Neuroimaging …, 2020 - neuroimaging.theclinics.com
Psychotic disorders are mental illnesses characterized by difficulties in reality testing. 1
Schizophrenia is a severe and chronic psychotic disorder with a lifetime prevalence of about …

[HTML][HTML] The role of norepinephrine in the pathophysiology of schizophrenia

V Mäki-Marttunen, OA Andreassen… - … & Biobehavioral Reviews, 2020 - Elsevier
Several lines of evidence have suggested for decades a role for norepinephrine (NE) in the
pathophysiology and treatment of schizophrenia. Recent experimental findings reveal …

Sex and gender differences in symptoms of early psychosis: a systematic review and meta-analysis

B Carter, J Wootten, S Archie, AL Terry… - Archives of Women's …, 2022 - Springer
First-episode psychosis (FEP) can be quite variable in clinical presentation, and both sex
and gender may account for some of this variability. Prior literature on sex or gender …

[HTML][HTML] Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: a longitudinal, community-based study …

AA Jones, KM Gicas, S Seyedin, TS Willi… - PLoS …, 2020 - journals.plos.org
Background The “trimorbidity” of substance use disorder and mental and physical illness is
associated with living in precarious housing or homelessness. The extent to which …